Cargando…
Alpha emitter radium-223 in patients with metastatic castration-resistant prostate cancer: A cost-utility analysis
Objective: To assess the cost effectiveness of radium-223 dichloride for patients with metastatic castration-resistant prostate cancer (mCRPC) in China. Materials and methods: A Markov model was developed to estimate the long-term health and economic outcomes of radium-223 plus best standard care (B...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633991/ https://www.ncbi.nlm.nih.gov/pubmed/36339555 http://dx.doi.org/10.3389/fphar.2022.1003483 |